Plant Summary


  Plant Information

TCMBank_ID:

TCMBANKHE004038

ID:

TCMBANKHE004038

植物拉丁名:

Ipomoea cairica [Syn. Ipomoea palmata ]
显示图片

功能与主治:

To clear heat and resolve toxin, disinhibit water and free strangury./Lung heat cough, inhibited urination, strangury, edema, swollen welling abscess and toxin of clove.

药用植物名:

五爪龙

药用部位:

Root or stem-leaf

药味:

Cold; Sweet; Bitter

经络:

Lung; Large Intestine; Liver

TCM_ID_id:

1152

TCMSP_id:

733


   植物对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN001812 alizarin SPECTRUM210850; KBio2_006002; Mitsui Alizarine B; 1,2-Dihydroxyanthraquinone; 32612_RIEDEL; ZINC03860973; Alizerine NAC; Alizarine Paste 20 percent Bluish; 4857-81-2; C37H34ClN2NaO6S2; Alizarine 3B; Deep Crimson Madder 10821E; SODIUM 3-({[(1E,4E)-4-[(2-CHLOROPHENYL)(4-{ETHYL[(3-SULFONATOPHENYL)METHYL]AMINO}PHENYL)METHYLIDENE]CYCLOHEXA-2,5-DIEN-1-YLIDENE](ETHYL)AMMONIO}METHYL)BENZENESULFONATE; 05560_FLUKA; CI 58000; C.I. Pigment Red 83C; BRN 1914037; Alizarin Red; Alizarine paste 20% bluish; C.I. Mordant Red 11C; KBioGR_002050; 333174_SIAL; 122777_SIAL; AIDS-001373; AKOS015916657; C.I. Mordant Red 11; SPBio_000613; CHEBI:16866; Hystazarin; Certiqual Alizarine; 1,2-dihydroxyanthra-9,10-quinone; D and C Orange No. 15; NCGC00095227-03; Hydrogen [4-[(2-chlorophenyl)[4-[Ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobe nzyl)ammonium Na salt; Alizerine Red IPP; Spectrum2_000397; AI3-18244; KBio1_001360; ALIZARIN GREEN; NCGC00095227-01; 72-48-0; NCI60_041501; alizarin ; 1,2-Dihydroxy-9,10-anthracenedione; Turkey Red W; Spectrum5_000150; 1,2-Dihydroxy-anthraquinone; Alizarine Red B2; 1,2-Dihydroxyanthrachinon; Sanyo Carmine L2B; Brilliant Acid Green; BG01793641; Alizarina; 1328-02-5; B0791; Alizarine Red L; Alizarine Lake Red IPX; Dihydroxy-9,10-anthracenedione; Anthraquinone, 1,2-dihydroxy-; Deep Crimson Madder 10821; Pigment red 83; Turkey Red (VAN); Alizarin; 1,2-Anthraquinonediol; Mitsui Alizarine BS; Alizarine Lake Red 2P; Brilliant Milling Green; Certiqual Alizarine D; NCGC00095227-02; BSPBio_001704; Alizarine Red IP; Alizarine Red IPP; SpecPlus_000320; Alizarinprimeveroside; potassium 3-[({4-[(2-chlorophenyl)(4-{ethyl[(3-sulfonatophenyl)methyl]iminio}cyclohexa-2,5-dien-1-ylidene)methyl]phenyl}(ethyl)amino)methyl]benzenesulfonate; Mordant Red 11; Eljon Madder M; D And C Orange Number 15; Sanyo Carmine l2BT; SDCCGMLS-0066502.P001; KBio2_000866; AIDS001373; 9,10-Anthracenedione, 1,2-dihydroxy-; D and C Orange Number 15D; NSC7212; Alizarine indicator; C01474; InChI=1/C14H8O4/c15-10-6-5-9-11(14(10)18)13(17)8-4-2-1-3-7(8)12(9)16/h1-6,15,18; ALIZARINE; MolPort-005-938-495; Turkey Red; 84754-86-9; EINECS 200-782-5; 1,2-Dihydroxy-9,10-anthraquinone; Alizarin B; MFCD00050440; W-110000; 1,2-dihydroxyanthracene-9,10-dione; 4-08-00-03256 (Beilstein Handbook Reference); NSC 7212; KBioSS_000866; 1,2-Dihydroxyanthrachinon [Czech]; I14-51626; SBB006481; Alizarine B; CCRIS 3530; Spectrum_000386; Spectrum3_000262; C.I. Pigment Red 83; NEPTUNE GREEN SG; Alizarine L paste; C.I. 58000C; KBio2_003434; Alizarine Red; KBio3_001204; Acid green 9; Alizarine Red B; LN: L C666 BV IVJ EQ FQ1; AC-20177; CBDivE_014227; Alizarine Lake Red 3P; Spectrum4_001555; DivK1c_006416; C.I. 58000; Eljon madder; Alizarine NAC C14H8O4 240.21 C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)O)O
TCMBANKIN005352 ergocornine C31H39N5O5 561.7 g/mol CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=CNC7=CC=CC(=C67)C5=C4)C)O
TCMBANKIN010879 ergocorninine C31H39N5O5 561.7 g/mol CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=CNC7=CC=CC(=C67)C5=C4)C)O
TCMBANKIN025505 tartaric acid tartaricacid; LS-188035 C4H6O6 150.09 g/mol C(C(C(=O)O)O)(C(=O)O)O
TCMBANKIN026617 rubiadin W1217; RTR-032746; AC1L3XTD; 1, 3-dihydroxy-2-methyl anthraquinone; NP-012908; UNII-CY0UH3X06R; KB-216455; AK111254; KSC937O7B; 1,3-dihydroxy-2-methyl-anthracene-9,10-dione; SCHEMBL1426928; LS-188104; FT-0687288; CCRIS 4533; 117-02-2; 1,3-dihydroxy-2-methylanthraquinone; AIDS-098142; MolPort-003-824-764; AC1Q6JWT; 9,10-Anthracenedione, 1,3-dihydroxy-2-methyl-; CY0UH3X06R; AJ-48018; A1-06841; Rubiadin, analytical standard; ST24036800; 4CN-2427; Rubiadin; Rubiadine; 1,3-dihydroxy-2-methyl-9,10-anthraquinone; ZINC4098705; 1,3-dihydroxy-2-methylanthracene-9,10-dione; DB-025540; NCGC00386035-01!1,3-dihydroxy-2-methylanthracene-9,10-dione; CTK8D7770; CHEBI:69533; DTXSID90151651; Q-100965; AKOS015914028; AIDS098142; MCULE-1867080462; I14-45158; C10402; CHEMBL251251 C15H10O4 254.24 g/mol CC1=C(C=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O
TCMBANKIN027639 succine acid
TCMBANKIN033702 citric acid InChI=1/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12; NCGC00090954-02; NCGC00090954-01; HSDB 911; CIT; Citric acid (8CI); BRN 0782061; NCIStruc2_000099; 27109_RIEDEL; AIDS-017733; 1,2,3-PROPANETRICARBOXYLIC ACID,2-HYDROXY (CITRIC ACID); citr; 27488_FLUKA; FEMA No. 2306; E 330; 27485_FLUKA; 27487_FLUKA; 77-92-9; C2404_SIGMA; 2-Hydroxytricarballylic acid; NCIOpen2_004502; F 0001 (polycarboxylic acid); EPA Pesticide Chemical Code 021801; AI3-06286; 245654-34-6; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-; Citretten; Kyselina citronova; 2-hydroxypropane-1,2,3-tricarboxylic acid; Anhydrous citric acid; Citrate standard for IC; C83155_SIAL; LS-2418; WLN: QV1XQVQ1VQ; 1,2,3-Propanetricarboxylic acid, 2-hydroxy- (9CI); NSC30279; .beta.-Hydroxytricarballylic acid; NSC 626579; FLC; NCI60_022579; LS-3185; 2-hydroxy-1,2,3-propanetricarboxylic acid; Caswell No. 221C; EINECS 201-069-1; 43136-35-2; 251275_SIAL; 38730_FLUKA; C4540_SIGMA; FEMA Number 2306; 4-03-00-01272 (Beilstein Handbook Reference); 3-Carboxy-3-hydroxypentane-1,5-dioic acid; Citric acid anhydrous (JAN); C00158; 12262-73-6; 240621_ALDRICH; AIDS017733; MLS001066346; Kyselina 2-hydroxy-1,2,3-propantrikarbonova [Czech]; 2-Hydroxypropanetricarboxylic acid; CCRIS 3292; KBio3_002740; NSC626579; D00037; SBB008922; Kyselina citronova [Czech]; Aciletten; NSC 30279; Anhydrous citric acid (JP15); 46933_SUPELCO; NCIOpen2_004062; Citric acid solution; CHEBI:30769; Citro; BSPBio_003240; NCIStruc1_000057; Uro-trainer; Citric acid, anhydrous (USP); W230618_ALDRICH; Citric acid [USAN:JAN]; H3cit; Chemfill; Hydrocerol A; Suby G; Oprea1_502996; Citric acid, anhydrous; SMR000471840; Citric acid anhydrous; Spectrum3_001850 C6H8O7 192.12 C(C(=O)O)C(CC(=O)O)(C(=O)O)O
TCMBANKIN035195 muricatin b C35H64O8 612.9 g/mol CCCCCCCCCCCCCC(C(C(CCC(C1CCC(O1)CCCCCC(CC2=CC(OC2=O)C)O)O)O)O)O
TCMBANKIN037277 Oleanolic acid Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid C30H48O3 457 C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H]
TCMBANKIN041636 prunasin SMR000470856; CHEMBL1871737; HMS2269N16; MLS000563196 C14H17NO6 295.29 C1=CC=C(C=C1)C(C#N)OC2C(C(C(C(O2)CO)O)O)O
TCMBANKIN042055 munjistin C15H8O6 284.22 g/mol C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)C(=O)O)O
TCMBANKIN042231 amygdalin (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile; (2R)-2-phenyl-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]acetonitrile; (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-acetonitrile; ethane; 2-(hydroxymethyl)-6-[[6-(methoxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]methoxymethyl]oxane-3,4,5-triol; methanenitrile; methylbenzene; molecular hydrogen; (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-ethanenitrile; C08325; CHEBI:17019; (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-acetonitrile; 29883-15-6; STOCK1N-52529; (-)-D-mandelonitrile beta-D-gentiobioside; (2R)-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy](phenyl)acetonitrile; A820093; SMP1_000103; Amygdalin; ethane; formonitrile; 2-(hydroxymethyl)-6-[[3,4,5-trihydroxy-6-(methoxymethyl)-2-oxanyl]methoxymethyl]oxane-3,4,5-triol; molecular hydrogen; toluene C20H27NO11 457.43 C1=CC=C(C=C1)C(C#N)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O
TCMBANKIN046208 furomollugin BG01539243; CHEMBL464791; 61658-41-1; W1942; METHYL 5-HYDROXYNAPHTHO[1,2-B]FURAN-4-CARBOXYLATE; AKOS032948373; MolPort-035-706-113; ZINC14492390; AFMYCYWCHKTNNE-UHFFFAOYSA-N; Naphtho[1,2-b]furan-4-carboxylic acid,5-hydroxy-,methyl ester C14H10O4 242.227 c1([H])c([H])c(c(O[H])c(C(OC([H])([H])[H])=O)c(c([H])c([H])o2)c23)c3c([H])c1[H]
TCMBANKIN058383 rubia akanera-i alizarin;SPECTRUM210850; KBio2_006002; Mitsui Alizarine B; 1,2-Dihydroxyanthraquinone; 32612_RIEDEL; ZINC03860973; Alizerine NAC; Alizarine Paste 20 percent Bluish; 4857-81-2; C37H34ClN2NaO6S2; Alizarine 3B; Deep Crimson Madder 10821E; SODIUM 3-({[(1E,4E)-4-[(2-CHLOROPHENYL)(4-{ETHYL[(3-SULFONATOPHENYL)METHYL]AMINO}PHENYL)METHYLIDENE]CYCLOHEXA-2,5-DIEN-1-YLIDENE](ETHYL)AMMONIO}METHYL)BENZENESULFONATE; 05560_FLUKA; CI 58000; C.I. Pigment Red 83C; BRN 1914037; Alizarin Red; Alizarine paste 20% bluish; C.I. Mordant Red 11C; KBioGR_002050; 333174_SIAL; 122777_SIAL; AIDS-001373; AKOS015916657; C.I. Mordant Red 11; SPBio_000613; CHEBI:16866; Hystazarin; Certiqual Alizarine; 1,2-dihydroxyanthra-9,10-quinone; D and C Orange No. 15; NCGC00095227-03; Hydrogen [4-[(2-chlorophenyl)[4-[Ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobe nzyl)ammonium Na salt; Alizerine Red IPP; Spectrum2_000397; AI3-18244; KBio1_001360; ALIZARIN GREEN; NCGC00095227-01; 72-48-0; NCI60_041501; alizarin ; 1,2-Dihydroxy-9,10-anthracenedione; Turkey Red W; Spectrum5_000150; 1,2-Dihydroxy-anthraquinone; Alizarine Red B2; 1,2-Dihydroxyanthrachinon; Sanyo Carmine L2B; Brilliant Acid Green; BG01793641; Alizarina; 1328-02-5; B0791; Alizarine Red L; Alizarine Lake Red IPX; Dihydroxy-9,10-anthracenedione; Anthraquinone, 1,2-dihydroxy-; Deep Crimson Madder 10821; Pigment red 83; Turkey Red (VAN); Alizarin; 1,2-Anthraquinonediol; Mitsui Alizarine BS; Alizarine Lake Red 2P; Brilliant Milling Green; Certiqual Alizarine D; NCGC00095227-02; BSPBio_001704; Alizarine Red IP; Alizarine Red IPP; SpecPlus_000320; Alizarinprimeveroside; potassium 3-[({4-[(2-chlorophenyl)(4-{ethyl[(3-sulfonatophenyl)methyl]iminio}cyclohexa-2,5-dien-1-ylidene)methyl]phenyl}(ethyl)amino)methyl]benzenesulfonate; Mordant Red 11; Eljon Madder M; D And C Orange Number 15; Sanyo Carmine l2BT; SDCCGMLS-0066502.P001; KBio2_000866; AIDS001373; 9,10-Anthracenedione, 1,2-dihydroxy-; D and C Orange Number 15D; NSC7212; Alizarine indicator; C01474; InChI=1/C14H8O4/c15-10-6-5-9-11(14(10)18)13(17)8-4-2-1-3-7(8)12(9)16/h1-6,15,18; ALIZARINE; MolPort-005-938-495; Turkey Red; 84754-86-9; EINECS 200-782-5; 1,2-Dihydroxy-9,10-anthraquinone; Alizarin B; MFCD00050440; W-110000; 1,2-dihydroxyanthracene-9,10-dione; 4-08-00-03256 (Beilstein Handbook Reference); NSC 7212; KBioSS_000866; 1,2-Dihydroxyanthrachinon [Czech]; I14-51626; SBB006481; Alizarine B; CCRIS 3530; Spectrum_000386; Spectrum3_000262; C.I. Pigment Red 83; NEPTUNE GREEN SG; Alizarine L paste; C.I. 58000C; KBio2_003434; Alizarine Red; KBio3_001204; Acid green 9; Alizarine Red B; LN: L C666 BV IVJ EQ FQ1; AC-20177; CBDivE_014227; Alizarine Lake Red 3P; Spectrum4_001555; DivK1c_006416; C.I. 58000; Eljon madder; Alizarine NAC C14H8O4 240.21 C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)O)O
TCMBANKIN058384 purpurin 81-54-9; EU-0000318; AIDS-001387; C.I. Natural Red 16; SDCCGMLS-0066870.P001; Smoke Brown G; 1,2,4-trihydroxyanthra-9,10-quinone; 229148_SIAL; NCGC00095346-02; NSC 10447; CCRIS 3527; Hydroxylizaric acid; 1,2,4-trihydroxyanthracene-9,10-dione; 1,2,4-Trihydroxyanthraquinone; InChI=1/C14H8O5/c15-8-5-9(16)14(19)11-10(8)12(17)6-3-1-2-4-7(6)13(11)18/h1-5,15-16,19; Purpurin; NCIMech_000036; SBB006444; C10395; SPBio_000133; 9,10-Anthracenedione, 1,2,4-trihydroxy-; C.I. 75410; Purpurine; C.I. Natural Red 8; ZINC03861633; CHEBI:8645; Spectrum3_001947; 9,10-Anthracenedione, 1,2,4-trihydroxy- (9CI); 82631_FLUKA; C.I. 1037; 1,2,4-Trihydroxyanthrachinon [Czech]; Anthraquinone, 1,2,4-trihydroxy-; Spectrum2_000037; BSPBio_003547; EINECS 201-359-8; 4-08-00-03568 (Beilstein Handbook Reference); NCGC00095346-01; NSC10447; AIDS001387; KBio3_002835; SPECTRUM1505300; NCI60_000107; 1,2,4-Trihydroxyanthrachinon; 1,2,4-Trihydroxy-9,10-anthraquinone; 1,2,4-Trihydroxy-9,10-anthracenedione; BRN 1887127; C.I. 58205; WLN: L C666 BV IVJ DQ EQ GQ C14H8O5 256.21 g/mol C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)O)O
TCMBANKIN058385 purpuroxanthin purpuroxan-thin;xanthopurpurin C14H8O4 240.21 g/mol C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC(=C3)O)O
TCMBANKIN058481 Rubianic acid 1-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxy-anthracene-9,10-dione; 1-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-anthracene-9,10-dione; 1-Hydroxy-2-((6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy)anthraquinone; 152-84-1; EINECS 205-808-9; beta-D-1-Hydroxy-2-anthraquinonyl 6-O-beta-D-xylopyranosylglucopyranoside; BRN 0071586; Rubierythric acid; 4-17-00-03462 (Beilstein Handbook Reference); Alizarin primeveroside; CCRIS 4531; 1-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione; Glucopyranoside, 1-hydroxy-2-anthraquinonyl 6-O-beta-D-xylopyranosyl-, beta-D-; Ruberythric acid; 1-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-9,10-anthraquinone; 1-hydroxy-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxy-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]anthracene-9,10-dione; alizarinprimeveroside C25H26O13 534.5 g/mol C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(C4=C(C=C3)C(=O)C5=CC=CC=C5C4=O)O)O)O)O)O)O)O
TCMBANKIN059494 rubimaillin;Mollugin C17H16O4 284.31 g/mol CC1(C=CC2=C(O1)C3=CC=CC=C3C(=C2C(=O)OC)O)C
TCMBANKIN060973 malic acid C18H32O2 280.4 g/mol CCCCCCCCC1=C(C1)CCCCCCC(=O)O
TCMBANKIN061019 muricatocin b C35H64O8 612.9 g/mol CCCCCCCCCCCCC(C1CCC(O1)C(CCC(CC(CCCCCC(CC2=CC(OC2=O)C)O)O)O)O)O
TCMBANKIN061509 trachelogenin C21H24O7 388.4 g/mol COC1=C(C=C(C=C1)CC2COC(=O)C2(CC3=CC(=C(C=C3)O)OC)O)OC
TCMBANKIN061510 tracheloside C27H34O12 550.6 g/mol COC1=C(C=C(C=C1)CC2COC(=O)C2(CC3=CC(=C(C=C3)OC4C(C(C(C(O4)CO)O)O)O)OC)O)OC

   植物对应的疾病
疾病ID 病名 疾病类型 MeSH 参考文献

   植物对应的靶点
靶点ID 基因名 基因别名 描述 染色体位置 Map_Location 基因类型